EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSFHEG00000013751
Gene Symbol: TAAR1
3 Cross references
427 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSFHEG00000008363
Gene Symbol: TAAR1
1 Cross references
400 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSFHEG00000008332
Gene Symbol: TAAR1
3 Cross references
425 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSFHEG00000008357
Gene Symbol: TAAR1
3 Cross references
369 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSFHEG00000008381
Gene Symbol: TAAR1
3 Cross references
384 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSFHEG00000008396
Gene Symbol: TAAR1
1 Cross references
384 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSFHEG00000012661
Gene Symbol: TAAR1
2 Cross references
349 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSFHEG00000012567
Gene Symbol: TAAR1
3 Cross references
353 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSFHEG00000022166
Gene Symbol: LOC105925551
3 Cross references
201 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSFHEG00000018234
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSFHEG00000018995
Gene Symbol: LOC105925691
3 Cross references
177 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSFHEG00000012213
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).